Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126090122 | 12609012 | 2 | F | 19881201 | 20160719 | 20160731 | 20160801 | EXP | ES-ALLERGAN-1645669 | ALLERGAN | CAMPISTOL JM, CASES A, BOTEY A, REVERT A.. ACUTE ALUMINIUM ENCEPHALOPATHY IN AN UREMIC PATIENT. NEPHORN. 1989;51:103-6 | 56.00 | YR | M | Y | 0.00000 | 20160801 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126090122 | 12609012 | 1 | PS | SUCRALFATE Unk | SUCRALFATE | 1 | Oral | 4 G, QD | 19183 | 4 | G | QD | |||||||
| 126090122 | 12609012 | 2 | SS | ALUMINIUM HYDROXIDE | ALUMINUM HYDROXIDE | 1 | Oral | 12 TABLETS, QD | 0 | 12 | DF | TABLET | QD | ||||||
| 126090122 | 12609012 | 3 | SS | ALUMINIUM HYDROXIDE | ALUMINUM HYDROXIDE | 1 | Oral | 6 TABLETS, QD | UNKNOWN | 0 | 6 | DF | TABLET | QD | |||||
| 126090122 | 12609012 | 4 | SS | ALUMINIUM HYDROXIDE | ALUMINUM HYDROXIDE | 1 | Oral | 4 TABLETS, QD | UNKNOWN | 0 | 4 | DF | TABLET | QD | |||||
| 126090122 | 12609012 | 5 | SS | CIMETIDINE | CIMETIDINE | 1 | Oral | 400 MG, QD | 0 | 400 | MG | QD | |||||||
| 126090122 | 12609012 | 6 | C | PHENYTOIN. | PHENYTOIN | 1 | U | 0 | |||||||||||
| 126090122 | 12609012 | 7 | C | PHENYTOIN. | PHENYTOIN | 1 | U | 0 | |||||||||||
| 126090122 | 12609012 | 8 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | U | 0 | |||||||||||
| 126090122 | 12609012 | 9 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126090122 | 12609012 | 1 | Gastrointestinal haemorrhage |
| 126090122 | 12609012 | 2 | Gastrointestinal haemorrhage |
| 126090122 | 12609012 | 5 | Gastrointestinal haemorrhage |
| 126090122 | 12609012 | 6 | Myoclonus |
| 126090122 | 12609012 | 7 | Seizure |
| 126090122 | 12609012 | 8 | Myoclonus |
| 126090122 | 12609012 | 9 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126090122 | 12609012 | LT |
| 126090122 | 12609012 | OT |
| 126090122 | 12609012 | DE |
| 126090122 | 12609012 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126090122 | 12609012 | Agitation | |
| 126090122 | 12609012 | Coma | |
| 126090122 | 12609012 | Confusional state | |
| 126090122 | 12609012 | Disorientation | |
| 126090122 | 12609012 | Drug ineffective | |
| 126090122 | 12609012 | Dysarthria | |
| 126090122 | 12609012 | Generalised tonic-clonic seizure | |
| 126090122 | 12609012 | Hyperreflexia | |
| 126090122 | 12609012 | Lethargy | |
| 126090122 | 12609012 | Myoclonus | |
| 126090122 | 12609012 | Parotitis | |
| 126090122 | 12609012 | Septic shock | |
| 126090122 | 12609012 | Toxic encephalopathy | |
| 126090122 | 12609012 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126090122 | 12609012 | 2 | 198512 | 0 | ||
| 126090122 | 12609012 | 5 | 198512 | 0 |